|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current Assets | |||||||
| Cash | |||||||
| Income tax receivable | |||||||
| Prepaid expenses | |||||||
| Cash and marketable securities held in Trust Account | |||||||
| Total Current Assets | |||||||
| Deferred offering costs | |||||||
| Cash and marketable securities held in Trust Account | |||||||
| Total Assets | |||||||
| Liabilities and Stockholders' Equity | |||||||
| Current Liabilities | |||||||
| Accrued expenses | |||||||
| Accounts payable and accrued expenses | |||||||
| Accrued offering costs | |||||||
| Income taxes payable | |||||||
| Promissory note - related party | |||||||
| Total Current Liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| Total Liabilities | |||||||
| Common stock subject to possible redemption, 32,131,082 and 32,572,779 shares at redemption value at September 30, 2019 and December 31, 2018, respectively | |||||||
| Stockholders' Equity: | |||||||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | |||||||
| Common stock | |||||||
| Class A Common Stock | |||||||
| Class B Common Stock | |||||||
| Additional paid-in capital | |||||||
| Retained earnings | |||||||
| Total Stockholders' Equity | |||||||
| Total Liabilities and Stockholders' Equity |
Loading...